These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 35326462)

  • 21. Vogt-Koyanagi-Harada syndrome in a 4-year old child.
    Cunningham ET; Demetrius R; Frieden IJ; Emery HM; Irvine AR; Good WV
    Am J Ophthalmol; 1995 Nov; 120(5):675-7. PubMed ID: 7485374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vogt-koyanagi-harada syndrome.
    Fang W; Yang P
    Curr Eye Res; 2008 Jul; 33(7):517-23. PubMed ID: 18600484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Work-up, diagnosis and management of acute Vogt-Koyanagi-Harada disease: a case of acute myopization with granulomatous uveitis.
    Mantovani A; Resta A; Herbort CP; Abu El Asrar A; Kawaguchi T; Mochizuki M; Okada AA; Rao NA
    Int Ophthalmol; 2007; 27(2-3):105-15. PubMed ID: 17484019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence, clinical characteristics, and causes of vision loss in children with Vogt-Koyanagi-Harada disease in South India.
    Martin TD; Rathinam SR; Cunningham ET
    Retina; 2010; 30(7):1113-21. PubMed ID: 20168275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A case of Vogt-Koyanagi-Harada-like uveitis secondary to dabrafenib/trametinib therapy for advanced melanoma.
    Brambati M; Giuffrè C; Marchese A; Bandello F; Modorati GM; Miserocchi E
    Eur J Ophthalmol; 2022 Jan; 32(1):NP109-NP113. PubMed ID: 32998540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vogt-Koyanagi-Harada
    Campos WR; Cenachi SPF; Soares MS; Gonçalves PF; Vasconcelos-Santos DV
    Ocul Immunol Inflamm; 2021 Jan; 29(1):124-127. PubMed ID: 31603703
    [No Abstract]   [Full Text] [Related]  

  • 27. VOGT-KOYANAGI-HARADA DISEASE-LIKE UVEITIS IN A PATIENT WITH ADVANCED MELANOMA TREATED BY SEQUENTIAL ADMINISTRATION OF NIVOLUMAB AND DABRAFENIB/TRAMETINIB THERAPY.
    Madoe A; Schauwvlieghe PP; Jacob J
    Retin Cases Brief Rep; 2023 Sep; 17(5):611-615. PubMed ID: 37643052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Harada-like syndrome post-Covishield vaccination: A rare adverse effect.
    Reddy Y; Pandey A; Ojha A; Ramchandani S
    Indian J Ophthalmol; 2022 Jan; 70(1):321-323. PubMed ID: 34937269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute-onset Vogt-Koyanagi-Harada like uveitis following Covid-19 inactivated virus vaccination.
    Chen X; Wang B; Li X
    Am J Ophthalmol Case Rep; 2022 Jun; 26():101404. PubMed ID: 35165663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Case with metastatic cutaneous malignant melanoma that developed Vogt-Koyanagi-Harada-like uveitis following pembrolizumab treatment.
    Enomoto H; Kato K; Sugawara A; Itabashi M; Kondo M
    Doc Ophthalmol; 2021 Jun; 142(3):353-360. PubMed ID: 33392895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vogt-Koyanagi-Harada Syndrome in a Group of Patients in Two Ophthalmology Referral Centers in Bogotá, Colombia.
    Guayacán CL; Galindo-Mendez B; de-la-Torre A
    Ocul Immunol Inflamm; 2018; 26(7):1123-1127. PubMed ID: 28910557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversal of Peripheral Iris Depigmentation Associated with Vogt-Koyanagi-Harada Disease.
    Tobaigy MF; AlBloushi AF; Al-Dhibi HA
    Ocul Immunol Inflamm; 2024 May; 32(4):424-428. PubMed ID: 36657743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Manifestations and Treatment of Vogt-Koyanagi-Harada Disease during Pregnancy and after Birth: A Case Report.
    Sanchez-Vicente JL; Moruno-Rodríguez A; De Las Morenas-Iglesias J; Gonzalez-Jauregui B; Franco-Ruedas C; Lechon-Caballero B; Talego-Sancha A; Rueda-Rueda T; Del Estad-Cabello A; López-Herrero F
    Ocul Immunol Inflamm; 2023 May; 31(4):830-837. PubMed ID: 35404732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unilateral Ocular Manifestations of Vogt-Koyanagi-Harada Disease.
    Tsui E; Bottini A; Ghadiali Q; Balaratnasingam C; Barbazetto I
    Ocul Immunol Inflamm; 2018; 26(8):1297-1300. PubMed ID: 29020488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case of probable Vogt-Koyanagi-Harada disease in a 3-year-old girl.
    Katsuyama A; Kusuhara S; Awano H; Nagase H; Matsumiya W; Nakamura M
    BMC Ophthalmol; 2019 Aug; 19(1):179. PubMed ID: 31409322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case Report: Ipilimumab-induced Multisystem Autoimmune-like Toxicities Suggestive of Vogt-Koyanagi-Harada-like Syndrome.
    Monferrer-Adsuara C; Hernández-Bel L; Hernández-Garfella ML; Remolí-Sargues L; Ortiz-Salvador M; Castro-Navarro V; Cervera-Taulet E
    Optom Vis Sci; 2021 Nov; 98(11):1309-1316. PubMed ID: 34510146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vogt-Koyanagi-Harada Syndrome in a Canadian First Nations Population.
    Kryshtalskyj MT; Roy M
    Ocul Immunol Inflamm; 2022 May; 30(4):894-900. PubMed ID: 33621146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycophenolate mofetil combined with systemic corticosteroids prevents progression to chronic recurrent inflammation and development of 'sunset glow fundus' in initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease.
    Abu El-Asrar AM; Dosari M; Hemachandran S; Gikandi PW; Al-Muammar A
    Acta Ophthalmol; 2017 Feb; 95(1):85-90. PubMed ID: 27535102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab for sight-threatening refractory pediatric Vogt-Koyanagi-Harada disease.
    Umran RMR; Shukur ZYH
    Mod Rheumatol; 2018 Jan; 28(1):197-199. PubMed ID: 26154298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vogt-Koyanagi-Harada disease: extensive vitiligo with prodromal generalized erythroderma.
    Wong SS; Ng SK; Lee HM
    Dermatology; 1999; 198(1):65-8. PubMed ID: 10026405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.